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Membrane proteinIntramembrane-cleaving proteases (I-CLiPs) are membrane embedded proteolytic enzymes. All substrates
identiﬁed so far are also membrane proteins, involving a number of critical cellular signaling as well as
human diseases. After synthesis and assembly at the endoplasmic reticulum, membrane proteins are
exported to the Golgi apparatus and transported to their sites of action. A number of studies have revealed
the importance of the intracellular membrane trafﬁcking in i-CLiP-mediated intramembrane proteolysis,
not only for limiting the unnecessary encounter between i-CLiPs and their substrate but also for their cleav-
age site preference. In this review, we will discuss recent advances in our understanding of how each i-CLiP
proteolysis is regulated by intracellular vesicle trafﬁcking. This article is part of a Special Issue entitled:
Intramembrane Proteases.
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Protease is an enzyme that catalyzes the hydrolysis of peptide bonds
within proteins. Nearly 2% of the proteins encoded by the human ge-
nome are proteases, making up one of the largest classes of enzymes
[1]. It is well known that proteases play critical roles in a plethora ofembrane Proteases.
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rights reserved.biological processes such as development, differentiation, cell migration,
immunity, wound healing and cell death.
Over the last decade or so, the new branch of proteases with
unique character, called as intramembrane-cleaving proteases
(i-CLiPs), has emerged [2]. To date, i-CLiPs are comprised of three
major classes of proteases, rhomboid (serine protease), site-2 prote-
ase (S2P) (metalloprotease), presenilin-type proteases including
γ-secretase and signal peptide peptidases (SPPs) (aspartyl protease).
They are all multispanning membrane proteins and enzymatically ac-
tive by themselves with the exception of γ-secretase, that is a complex
of four proteins including catalytic subunit presenilin. All of their sub-
strates identiﬁed so far are alsomembrane proteins, involving a number
of critical cellular signaling as well as human diseases. Despite the
2856 Y. Morohashi, T. Tomita / Biochimica et Biophysica Acta 1828 (2013) 2855–2861hydrophobic nature of the lipid bilayer, these iCLiPs are somehow able
to hydrolyze the peptide bond within the transmembrane segment of
their substrate. The precise mechanism of action whereby these
i-CLiPs catalyze proteolysis in a lipid bilayer has been a subject of inten-
sive studies [3], and great strides have been made in understanding
them especially since the ﬁrst X-ray crystal structure of rhomboid
family protease has been revealed. These are reviewed elsewhere in
this special issue (see articles from Kroos and Akiyama; Wolfe;
Lemieux) therefore we are not going into the details; instead we will
focus on the other aspect of i-CLiP-mediated proteolysis.
Aberrant activation of proteases can be detrimental to the cells,
therefore their activity must be tightly regulated tomake sure that pro-
teolysis occurs in the right place at the right time. Processing by i-CLiP is
no exception considering that most of them seem to exist in an active
state except for γ-secretase, which requires assembly of four subunits
and endoproteolysis of catalytic subunit presenilin. It is widely known
that there are several ways to control proteolytic reaction. For example,
in the case of proteasome, substrates should be ubiquitinated so that
only proteins destined for degradation are recognized. Another exam-
ple is zymogen processing. Several proteases are ﬁrst synthesized as a
precursor in an inactive conformation. Once they reach to the site of ac-
tion, the self-inactivating “prodomain” peptide is removed to put them
into operation. In the case of i-CLiPs-mediated proteolytic processing,
because both enzymes and substrates known to date are all membrane
proteins asmentioned above, there is another way to control their reac-
tion — membrane trafﬁcking. The general theme of the regulation of
intramembrane proteolysis by membrane trafﬁcking is to limit the
encounter between protease and its substrate until it is necessary as
seen in the S2P and rhomboid-mediated processing. Moreover there is
another important aspect of intramembrane proteolysis that could be
affected bymembrane trafﬁcking. As for γ-secretase-mediated process-
ing in particular, subcellular location where proteolysis takes place
affects the cleavage site selection and consequently the property of
proteolytic products, which is critical both in the physiological and
pathological processes.
Membrane proteins are synthesized, properly folded and assembled
in the endoplasmic reticulum (ER), exported to the Golgi apparatus and
transported to their sites of action. A number of factors and signals/motifs
that control trafﬁcking or sorting of ‘cargo’ proteins to a certain organelle
have been revealed so far, and cells seem to exploit these regulatory
mechanisms to minimize the unwanted proteolytic reaction. In addition,
especially for S2P and presenilin-type i-CLiPs, the ‘priming’ cleavage is re-
quired formaking substrates available for the subsequent intramembrane
proteolysis [2], and this priming cleavage also seems to be a subject of theS2P
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Golgi
ER
Steady-state
Insig SCAP
SC
Insig
sec24
sec2
Fig. 1. SREBP procregulation bymembrane trafﬁc. In this review, wewill discuss recent ad-
vances in our understanding of how each i-CLiP proteolysis is regulated
by intracellular vesicle trafﬁcking.We startwith the best studied example
found in SREBP processing by S2P, and then go on to the trafﬁcking
regulation of the other iCLiP-mediated proteolysis.2. Site-2 protease (S2P)
2.1. SREBP
When the cellular cholesterol level drops, a subset of genes required
for lipid synthesis is upregulated by the controlled release of a mem-
brane tethered transcription factor called sterol regulatory element bind-
ing protein (SREBP) [4]. SREBP is synthesized as a membrane bound
precursor containing two transmembrane domains, theN-terminal tran-
scription factor domain and the C-terminal regulatory domain. In 1994
[5], it was found that the proteolytic activities are required for the liber-
ation of the N-terminal transcription activator domain — SREBP is ﬁrst
cleaved at “site-1” in its luminal loop region between two membrane-
spanning helices then at “site-2”, which is located within the ﬁrst trans-
membrane domain. Site-2 protease (S2P) was identiﬁed in a screen to
identify the protease responsible for site-2 cleavage [6]. S2P is a
multispanning membrane protein and has an HEXXH zinc-binding
motif common to the active site ofmetalloproteases, but in its hydropho-
bic region, ﬁtting perfectly with the location of site-2 cleavage site in
SREBP.
Proteolytic processing of SREBP is elegantly controlled by a feedback
mechanism involving protein–protein interactions andmembrane traf-
ﬁcking in response to the cellular content of cholesterol (Fig. 1). SREBP
normally exists in complex with a protein called SCAP [7]. SCAP is a
polytopic membrane protein and has the sterol-sensing domain (SSD)
in the middle, and the C-terminal multiple WD repeats which interact
with the regulatory domain of SREBP. When cells are with high choles-
terol, cholesterol binds to SSD of SCAP to induce conformational change,
allowing it to interactwith Insig, the ER retention factor for SREBP–SCAP
complex [8]. Interaction with Insig prevents SCAP from binding to
Sec24, a component of COPII vesicle coat complex, thereby inhibiting
the export of SREBP–SCAP complex from ER [9]. However, in sterol-
depleted cells, conformation of SCAP without cholesterol is altered to
reduce the afﬁnity for Insig. Then SREBP–SCAP complex interacts with
Sec24 to be exported to the Golgi, where S1P and S2P reside. Once
SREBP–SCAP complex reaches the Golgi apparatus, SREBP is successive-
ly cleaved by these membrane-bound proteases.S2P S2P
SREBP
Cholesterol depleted
AP
SCAP
Insig
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2857Y. Morohashi, T. Tomita / Biochimica et Biophysica Acta 1828 (2013) 2855–28612.2. Other S2P substrates
SREBP is not the sole substrate for S1P and S2P. Stress response tran-
scription factors ATF6, OASIS and CREB-H are also cleaved by these pro-
teases under stress-induced condition [10]. Remarkably, the regulatory
mechanism of their proteolytic processing is very similar to the one
used for SREBP processing. In the case of ATF6 for instance, ER chaper-
one BiP normally prevents ATF6 from being exported from the ER by
acting as a retention factor, a role similar to the one Insig plays for
SREBP, although BiP is a soluble luminal protein whereas Insig is a
membrane spanning protein [11]. It is postulated that when unfolded
proteins accumulate in the ER, ATF6 dissociates from BiP and the Golgi
localization signals in its luminal region is exposed. As a result, ATF6
translocates from the ER to the Golgi where it is sequentially cleaved
by S1P and S2P.
3. Rhomboid
3.1. Spitz
InDrosophila, Spitz (Spi) is expressed as amembrane tethered precur-
sor at the ER. Export of Spi from the ER requires Star, a type II membrane
protein associatedwith Spi to act as a chaperone [12,13]. In the absence of
Star, Spi is retained in the ER via a PLCγ dependentmechanism [14]. Once
exported from the ER, Spi reaches the Golgi or Rab4/Rab14 positive
endosomes where Rhomboid-1 resides, and is cleaved to release soluble
EGF ligand in the lumen [15,16] (Fig. 2). It has also been reported that
Star itself can be a substrate for rhomboid, adding another layer of regu-
lation for the trafﬁcking and processing of Spi [17]. In addition,
rhomboid-2 and -3 that are also capable of cleaving Spi are found in the
ER [18]. Thus, Spi and Star processing might also occur in this organ-
elle, although this ER-derived form seems to be retained there and
does not actively participate in the signaling. Whether this
“compartmentalization” mechanism can respond to the external
stimuli — in other words, is Spi trafﬁcking and subsequent process-
ing by Rhomboid are accelerated in response to the demand for
EGF ligand, as it has been seen in SREBP processing by S1P and S2P
remain elusive. Interestingly, it has recently been shown that some
of the catalytically inactive rhomboid-like proteins, or “iRhoms”,
negatively regulate EGF signaling by enhancing ER-associated degra-
dation (ERAD) of EGF precursor inDrosophila [19], serving as another
layer of regulatorymechanism for rhomboid-mediated EGF signaling
to limit the interaction between protease and its substrate (Fig. 2).
Interestingly, one of the mammalian counterpart iRhom2 has been
shown to enhance ER export of ADAM17/TNFα-converting enzyme
(TACE) to promote TNFα production, suggesting that the functions
of these rhomboid-like proteins are context-dependent [20].Spitz
Golgi
ER
Rhom
Star
iRhom
Fig. 2. Spitz processin3.2. Adhesins
In apicomplexan parasites, rhomboid-mediated intramembrane
proteolysis seems regulated in a trafﬁcking dependent manner. In
Toxoplasma gondii and Plasmodium falciparum, some rhomboids
such as TgROM4/5 and PfROM4, and their substrate adhesins/
microneme proteins (MICs) have been shown to localize on the plas-
mamembrane and in TGN/endosome related apical organelles called
microneme, respectively. When these parasites invade host cell,
adhesins/MICs translocate to the plasma membrane and bind to the
cognate receptors on the surface of the host cell. During the invasion,
these adhesins/MICs are transported by actomyosin contractilemachin-
ery to the posterior end of the parasite where TgROM5 or PfROM4 is
localized and subsequently cleaved by them to complete the invasion
[21].
4. γ-Secretase
γ-Secretase comprises four membrane protein subunits, presenilin,
nicastrin, Aph-1 and Pen2 [22,23]. Presenilin contains two signature
motifs, YD in TMD6 and GXGD in TMD7, containing aspartate residues
critical for the catalysis. γ-Secretase cleaves a number of type I
membrane proteins with relatively large extracellular domain. In-
terestingly, removal of this extracellular domain designated as
“ectodomain shedding” has been shown to be the prerequisite and
therefore rate-limiting regulatory step, for γ-secretase-mediated
intramembrane cleavage. Of over 100 γ-secretase substrates
reported so far, two have been extensively studied not only for
their intramembrane proteolysis but also for their trafﬁcking – APP
and Notch. γ-Secretase has a unique character in terms of its cleav-
age site preference – it cuts the transmembrane domain of the sub-
strate at several different positions. In the case of APP processing,
γ-secretase processing yields two types of product, amyloid-β peptide
(Aβ) secreted either extracellularly or into the lumen of the vesicle, and
the intracellular domain (ICD) released into the cytosol and eventually
entering into the nucleus. As for Notch processing, Notch ICD (NICD)
goes into nucleus after its liberation and forms transcription activating
complex, binds to the downstream target genes to drive its expression.
Aβ-like fragments dubbed “Nβ” are also produced simultaneously and
released into extracellular space; however their biological signiﬁcance is
not clear [24].
It has also been clearly demonstrated that presenilin needs to be as-
sembled with other three subunits to exert its full proteolytic potential
[23],while recombinant presenilin protein itself harbored the proteolytic
activity in an in vitro assay [25]. Atypical ER-retention signals have been
found in TMD4 and 9 in PS, TMD1of Pen2 and TMDofNct, some ofwhich
are recognized by an ER-retrieval factor Rer1 [26–29]. Once γ-secretaseRhom
iRhom
ERAD
g by rhomboid.
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enzyme is exported from ER to the cell surface along the constitutive
õsecretory pathway [30,31]. However, the behavior of the active
γ-secretase complex after reaching the plasma membrane and the
mechanism that control its trafﬁcking had been enigmatic basically
due to the lack of probe that speciﬁcally detects fully-assembled
complex. Previous studies (e.g. analyses of the sites where the
substrates accumulate upon γ-secretase inhibition) suggest that
γ-secretase activity might spread along the endocytic and recycling
pathway such as TGN, plasmamembrane, endosomes and lysosomes
[32–38]. Notably, distinct cleavage site preference has been observed
with different lipid compositions or under manipulation of endocytic
activity suggesting that localization of γ-secretase is important to
determine its proteolytic product repertoire [39,40]. Given the fact
that aggregation propensity of Aβ as well as signaling competence
of NICD critically depends on their cleavage sites, it is crucial to get
a good grasp of the precise mechanism of γ-secretase trafﬁcking. In
this regard, we have recently found that γ-secretase is constitutively
internalized via clathrin-mediated endocytosis and this pathway is reg-
ulated by CALM, which has been recently identiﬁed as a novel genetic
risk factor for AD (Morohashi et al., unpublished data).
Here we focus on the two major γ-secretase substrates Notch and
APP, and summarize the relationship between their trafﬁcking and
intramembrane proteolysis.
4.1. Notch
Notch receptor is normally expressed as heterodimeric single-pass
membrane protein with a type I orientation at the cell surface [41]. This
heterodimer is generated en route to the cell surface by furin-type
convertase (S1 cleavage). When the ligand on the neighboring cells
binds, a disintegrin andmetalloprotease (ADAM) family protease cleaves
at the short extracellular portion of the membrane-bound Notch
C-terminal fragment (S2 cleavage). The resulting stub then becomes a
substrate for γ-secretase and is cleaved at the cytoplasmic edge (S3) as
well as multiple sites in the middle (S4) of its transmembrane domain
(Fig. 3).
Although the importance of Notch receptor endocytosis has already
been established in late 1990s, during the past several years the addi-
tional important clues came from a series of elegantly performedFig. 3. Notch processingenetic studies in Drosophila. Bilder and colleagues reported that factors
promoting endocytosis such as dynamin, rab5 and syntaxin 7 are re-
quired for ligand-dependent Notch signaling, while loss of some compo-
nents of ESCRT complex which sort ubiquitinated endocytic cargo from
early endosomes into the intraluminal vesicle (ILV) ofmultivesicular bod-
ies (MVBs) resulted in an aberrant ectopic activation of Notch signaling
[42,43], indicating that endocytosis and endosomal sorting of Notch are
important for the γ-secretase-mediated intramembrane cleavage and
signaling.
Factors that hold the key here are E3 ubiquitin ligases, as
ubiquitination is known to be important not only for the proteasomal
degradation but also for the endosomal sorting. Several E3 ligases have
been implicated in the Notch signaling including Cbl, suppressor of
Deltex/Itch/AIP4, Nedd4, Deltex and Sel-10/Fbxw7 [44]. The current
model describes the trafﬁcking and processing of Notch as follows:
After ligand binding and subsequent ectodomain shedding, Notch
is ubiquitinated and internalized via dynamin-dependent pathway.
Endocytosed Notch traveled through endo-lysosomal compartment
until sorting into ILV of MVB by ESCRT machinery and eventually
get degraded in the lysosome. Deltex is involved in the lysosomal
sorting and ligand-independent activation of Notch, which requires
γ-secretase activity as well as endolysosomal trafﬁcking regulators
HOPS and AP-3 [45]. Signals can be sent to the nucleus while Notch
C-terminal stub is on the limiting membrane but not anymore after
it is incorporated into ILV as signal competent NICD would be re-
leased into its luminal space. Although key players have been identi-
ﬁed from genetic studies, most of them are still waiting to be put into
place to complete the picture outlined above. Further cell biological
studies will clarify the mechanism whereby Notch endocytosis and
sorting afterwards are regulated.
4.2. APP
APP is metabolized via two different routes— non-amyloidgenic and
amyloidgenic pathways [46]. The difference between them is the prote-
ase that removes the extracellular domain of APP, where its processing
occurs and at which position of extracellular domain it cleaves. In
non-amyloidogenic pathway, ectodomain shedding is executed by
ADAM family metalloproteases (called ‘α-secretase’), most probably on
the cell surface, that proteolyzes at a position very close to themembranePM
g by γ-secretase.
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amyloidogenic pathway, a membrane-bound aspartyl protease called
BACE1 (a.k.a., β-secretase) is responsible for this step on endosomes
and/or TGNwhere luminal pH is relatively low. This BACE1 cleavage oc-
curs atmore distal position frommembrane boundary, yielding slightly
longer βCTF comprised of 99-amino acid residues. Both αCTF and βCTF
become substrates for γ-secretase once they are generated. They could
be cleaved wherever they come in contact with γ-secretase along the
endocytic pathway and TGN in a similar manner to that in Notch cleav-
age. Thus, asmentioned above, the processing of APP seemsmostly reg-
ulated at the level of ectodomain shedding, rather than the γ-secretase
processing (Fig. 4).
APP has several knownmotifs that control intracellular trafﬁcking in
its cytosolic C-terminal tail. The most extensively studied one so far is
NPTY sequence, a typical binding motif for PTB-domain containing
clathrin adaptors [47]. Mutational study revealed that this motif is im-
portant for the internalization of APP and subsequent Aβ generation
[48]. A number of adaptor proteins have also been found, including
Fe65 family, X11 family, Dab1, Jip1b, ARH and Numb etc [49]. Disrup-
tion of their function, in many cases, leads to a prolonged residence at
the cell surface and thus decreased Aβ generation. Although direct in-
volvement of clathrin in APP internalization has not been tested so far,
clathrin adaptor protein CALM, one of the recently identiﬁed genetic
risk factors for AD, has been shown to regulate the endocytosis of APP
and Aβ pathology inmodelmice, supporting the idea that APP is consti-
tutively internalized via clathrin mediated pathway [50].
In addition to the NPTYmotif, APP C-terminus has two other poten-
tial trafﬁcking motifs, YTSI and YKFF, which fulﬁll the minimal consen-
sus for YXXø signal for binding of clathrin adaptor AP complex μ subunit
[47]. The Tyr residue in YTSI sequence has been shown to be critical for
efﬁcient basolateral sorting in polarized MDCK cells [51], whereas the
latter YKFF has recently been shown to bind μ4 subunit of AP-4 [32].
Among ﬁve of AP complexes identiﬁed so far, AP-4 is known not to
bind to clathrin. Instead, it regulates TGN-endosome transport. In the
case of APP, disruption of the interaction with AP-4 causes its accumu-
lation in the TGN and increased Aβ and AICD generation as a result of
enhanced γ-secretase processing.
During the past several years, the TGN-endosome transport has
attracted much attention from the ﬁeld for another reason. The Vps10p-
related type I transmembrane protein sorLA/LR11, genetically associatedFig. 4. APP processingwith AD, is also implicated in TGN-endosome trafﬁcking of APP by regu-
lating its endosomal sorting [52,53]. The expression level of SorLA/LR11
correlates with the level of Aβ in the brains of AD patients as well as in
the cultured cells. Loss of SorLA/LR11 expression leads to endosomal ac-
cumulation of APP aswell as increasedAβ generation. However, function-
al interaction between sorLA/LR11 and AP-4 remains to be determined.
Regarding the regulatory role of APP cytoplasmic domain, it remains
an important and unanswered question whether the trafﬁcking of APP
holoprotein and CTFs is regulated by common mechanisms. It has
been suggested that once the extracellular domain of APP is removed
by α- or β-secretase, CTF is destined for lysosomal degradation [54].
Future studies will clarify if the existence of APP extracellular domain
affects its cellular itinerary. Nevertheless, these results suggest that
APP is constitutively cycles between plasma membrane, endosomes
and TGN, and alteration in this recycling machinery would result in
the change in the production of Aβ, thus critical for the etiology of AD.
It is important to note that Aβ metabolism has been shown to be
affected by neuronal activity [55]. Pharmacologicalmanipulation in hip-
pocampal slice cultures revealed that the level of activity correlates
with the amount of Aβ secreted by affecting β-secretase cleavage, and
later it has been shown that this activity-induced Aβ generation re-
quires dynamin-dependent endocytosis [56]. In addition, it has recently
been shown that neuronal activity also affects the conformation of
γ-secretase catalytic subunit presenilin and Aβ40/42 ratio through
exocytic trafﬁcking activity that can be blocked by tetanus toxin treat-
ment [57]. Whether this is a regulation in a narrow sense – in other
words whether Aβ forms a part of feedback loop – or is it just the result
of a coincidental enhanced/decreased cleavage by β- and γ-secretases
due to the change in endocytic/exocytic rate caused by neuronal activ-
ity, remains unknown.
5. Signal peptide peptidase (SPP)
SPP is a member of presenilin-like intramembrane aspartyl prote-
ases. It has two signature motifs containing catalytic pair of aspartates
YD and GXGDwithin transmembrane domains, similar but with an op-
posite orientation to that of presenilin [58]. Therefore it is not surprising
that SPP cleaves type II transmembrane proteins which have opposite
membrane topology to the substrates of γ-secretase. In human SPP sub-
family consists of ﬁvemembers, SPP, SPPL2a, SPPL2b, SPPL2c and SPPL3.PM
by γ-secretase.
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lar localization. For example, SPP mainly localizes at the ER whereas
SPPL2a at the late endosome/lysosome, SPPL2b at the plasma mem-
brane, SPPL3 at ER and/or Golgi [59–63] (and there is a possibility that
SPPL2c is a pseudogene [58]). As for SPP, it has been shown to cleave
MHC class I signal peptide in the ER, so in this case membrane trafﬁck-
ing regulation does not seem to be required.
5.1. TNFα
In remarkable resemblance to the γ-secretase mediated Notch pro-
cessing, SPPL2a and SPPL2b have been shown to cleave type IImembrane
protein tumor necrosis factor-α (TNFα) to liberate intracellular domain,
which transmits signal to the nucleus to induce IL-12 expression [60]. In-
terestingly, depletion of either SPPL2a or b almost completely abolished
IL-12 production, suggesting that they somehow act in concert for this
signal transduction, while they show distinct subcellular localization.
Whether TNFα processing occurs constitutively or in a regulatedmanner
by compartmentalization, and how cells distinguish SPPL2a- and SPPL2b-
mediated processing of TNFα, remain elusive. What determines the late
endosomal/lysosomal sorting of SPPL2a through its C-terminus? Further
identiﬁcation of substrates as well as retention/sorting factors for SPP
subfamily proteases will help to gain more insights into the regulatory
mechanism for their proteolysis.
6. Perspective
Over a decade, the power of the genetic and cell biological studies
has greatly helped us to understand how i-CLiP processing is regulated
by membrane protein trafﬁc. GFP and live cell imaging technologies
have also expand our knowledge regarding functional relationships be-
tween the vesicle trafﬁcking and the atypical cleavage reaction. Howev-
er, themolecular details still remain elusive especially as towhat kind of
small GTPases, adaptors, vesicle tethering factors and motor proteins
are involved in these processes. Recent advances in mass spectrometric
analyses have provided a chance to clarify thewhole picture of protein–
protein/protein–lipid interactions involved in i-CLiP-mediated cleavage
[64]. Development of tools to detect endogenous i-CLiPs and their
substrates in immunoﬂuorescence analysis is also crucial to answering
these fundamental questions. In addition, several small chemicals
have been identiﬁed as regulatory compounds for vesicular trafﬁcking
by chemical biology studies [65]. Identiﬁcation of regulatory mecha-
nisms for i-CLiP processing using such innovative methods will shed
light on the ways these proteases regulate crucial biological processes,
and open the possibility for the novel therapeutics against several
diseases, such as AD.
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